Skip to Main Content

Paper Details

Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization.
Arthritis Rheumatol
10
2023
Atherosclerosis, B4GALNT3, CAC, DM, MI, RIN3, SERPINA1, SOST, Sclerostin, atherosclerosis, atherosclerosis-related diseases, cis-SNPs, coronary artery, hypertension, myocardial infarction, sclerostin, type 2 DM, type 2 diabetes mellitus
Author NameAffiliation
Eleanor WheelerInstitute of Metabolic Science, University of Cambridge School of Clinical Medicine
April HartleyBristol Medical School, University of Bristol
John P KempBristol Medical School, University of Bristol, and Institute for Molecular Bioscience, The University of Queensland, and The University of Queensland Diamantina Institute
Patricia A PeyserSchool of Public Health, University of Michigan ann arbor
Patricia A PeyserSchool of Public Health, University of Michigan ann arbor
Maryam KavousiUniversity Medical Center
Marcus E Kleber
George DedoussisHarokopio University
Eleftheria ZegginiInstitute of Translational Genomics, German Research Center for Environmental Health, and Technical University of Munich (TUM) and Klinikum Rechts der Isar, TUM School of Medicine
Claes OhlssonDepartment of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg
Claes OhlssonDepartment of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg
Nicholas J WarehamInstitute of Metabolic Science, University of Cambridge School of Clinical Medicine
Claudia LangenbergInstitute of Metabolic Science, University of Cambridge School of Clinical Medicine, Berlin Institute of Health at Charite-Universitatsmedizin Berlin
George Davey SmithBristol Medical School, University of Bristol
George Davey SmithBristol Medical School, University of Bristol
Jon H TobiasBristol Medical School, University of Bristol, and Musculoskeletal Research Unit
  • 1 - 16

Datasets